X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (987) 987
Publication (62) 62
Book Review (23) 23
Newspaper Article (18) 18
Book Chapter (10) 10
Book / eBook (6) 6
Conference Proceeding (2) 2
Trade Publication Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (444) 444
psychiatry (370) 370
neurosciences (342) 342
pharmacology & pharmacy (323) 323
male (288) 288
index medicus (264) 264
clinical neurology (232) 232
adult (194) 194
female (174) 174
animals (171) 171
middle aged (122) 122
brain (96) 96
anxiety (95) 95
rats (82) 82
serotonin (77) 77
depression (72) 72
panic disorder (69) 69
research (65) 65
double-blind method (63) 63
antidepressants (61) 61
psychopharmacology (61) 61
double-blind (58) 58
mice (58) 58
brain - metabolism (57) 57
brain - drug effects (52) 52
young adult (50) 50
pet (48) 48
aged (45) 45
benzodiazepines (45) 45
pharmacology (45) 45
analysis (42) 42
drug therapy (41) 41
receptors (41) 41
treatment outcome (41) 41
anxiety disorders - drug therapy (40) 40
drugs (40) 40
positron-emission-tomography (40) 40
serotonin uptake inhibitors - therapeutic use (40) 40
dose-response relationship, drug (39) 39
addiction (38) 38
major depression (38) 38
time factors (38) 38
usage (38) 38
dopamine (37) 37
biochemistry & molecular biology (36) 36
cross-over studies (35) 35
health aspects (35) 35
neuroimaging (34) 34
rat-brain (34) 34
care and treatment (33) 33
antidepressive agents - therapeutic use (32) 32
in-vivo (31) 31
noradrenaline (31) 31
psychology, clinical (31) 31
rat (31) 31
sleep (31) 31
substance abuse (31) 31
alcohol (30) 30
article (29) 29
blood pressure - drug effects (29) 29
comorbidity (29) 29
magnetic resonance imaging (29) 29
brain - diagnostic imaging (28) 28
gaba (28) 28
obsessive-compulsive disorder (28) 28
binding (27) 27
dosage and administration (27) 27
heart rate - drug effects (27) 27
multidisciplinary sciences (27) 27
posttraumatic-stress-disorder (27) 27
risk factors (27) 27
anxiety disorders (26) 26
idazoxan (26) 26
adolescent (25) 25
anxieties (25) 25
clonidine (25) 25
flumazenil (25) 25
healthy-volunteers (25) 25
norepinephrine (25) 25
physiological aspects (25) 25
studies (25) 25
anxiety disorders - physiopathology (24) 24
binding sites (24) 24
brain - physiopathology (24) 24
depression, mental (24) 24
biomedicine (23) 23
clinical trials (23) 23
insomnia (23) 23
mood (23) 23
parkinson's disease (23) 23
paroxetine (23) 23
pharmacology/toxicology (23) 23
positron emission tomography (23) 23
prefrontal cortex (23) 23
psilocybin (23) 23
serotonin - metabolism (23) 23
internal medicine (22) 22
medicine, general & internal (22) 22
alcoholism (21) 21
binding-sites (21) 21
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Neuropharmacology, ISSN 0028-3908, 11/2018, Volume 142, pp. 1 - 6
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 6/2013, Volume 27, Issue 6, pp. 479 - 496
Amphetamine was discovered over 100 years ago. Since then, it has transformed from a drug that was freely available without prescription as a panacea for a... 
amphetamine | drug formulations | Abuse liability | microdialysis | attention deficit hyperactivity disorder (ADHD) | lisdexamfetamine | FREELY MOVING RATS | HEALTHY ADULT VOLUNTEERS | PSYCHIATRY | DEFICIT HYPERACTIVITY DISORDER | DOPAMINE TRANSPORTER OCCUPANCY | SALTS EXTENDED-RELEASE | NEUROSCIENCES | MINIMAL BRAIN-DYSFUNCTION | CLINICAL NEUROLOGY | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | MEDIAL PREFRONTAL CORTEX | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | LISDEXAMFETAMINE DIMESYLATE | Central Nervous System Stimulants - pharmacology | Dextroamphetamine - pharmacology | Prodrugs | Amphetamine - therapeutic use | Humans | Amphetamine - pharmacology | Dextroamphetamine - therapeutic use | Amphetamine - adverse effects | Attention Deficit Disorder with Hyperactivity - drug therapy | Dextroamphetamine - adverse effects | Animals | Central Nervous System Stimulants - therapeutic use | Lisdexamfetamine Dimesylate | Central Nervous System Stimulants - adverse effects | Amphetamine-Related Disorders - prevention & control | Adolescent | Drug Design | Adult | Amphetamine-Related Disorders - epidemiology | Narcolepsy - drug therapy | Child | Safety and security measures | Laws, regulations and rules | Attention-deficit hyperactivity disorder | Amphetamines | Chemical properties | Amphetamine abuse | Drug therapy | Risk factors | Review
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 11/2010, Volume 24, Issue 11, pp. 1577 - 1601
Sleep disorders are common in the general population and even more so in clinical practice, yet are relatively poorly understood by doctors and other health... 
consensus | treatment | Sleep | parasomnia | circadian rhythm disorder | insomnia | DOXEPIN 1 MG | LONG-TERM | PSYCHIATRY | SLOW-WAVE SLEEP | NEUROSCIENCES | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | RESTLESS LEGS SYNDROME | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | QUALITY-OF-LIFE | TREATING DEPRESSIVE-DISORDERS | PROLONGED-RELEASE MELATONIN | EVIDENCE-BASED GUIDELINES | Sleep Wake Disorders - economics | Meta-Analysis as Topic | Hypnotics and Sedatives - adverse effects | Sleep Wake Disorders - drug therapy | Humans | Middle Aged | Male | Hypnotics and Sedatives - therapeutic use | Sleep Wake Disorders - complications | Sleep Initiation and Maintenance Disorders - complications | Chronobiology Disorders - drug therapy | Time Factors | Sleep Initiation and Maintenance Disorders - economics | Neurotransmitter Agents - pharmacology | Aged, 80 and over | Female | Chronobiology Disorders - diagnosis | Child | Neurotransmitter Agents - physiology | Hypnotics and Sedatives - pharmacokinetics | Sleep Initiation and Maintenance Disorders - diagnosis | Neurotransmitter Agents - metabolism | Sleep Wake Disorders - diagnosis | Treatment Outcome | Substance Withdrawal Syndrome | Evidence-Based Medicine | Consensus | Randomized Controlled Trials as Topic | Pregnancy | Cognitive Therapy | Aged | Sleep Initiation and Maintenance Disorders - drug therapy | Health maintenance organizations | Practice guidelines (Medicine) | Care and treatment | Circadian rhythm sleep disorders | Standards | Medical personnel | Circadian rhythms | Health care | Disorders | Clinical trials | Rhythm | Doctors | Literature reviews | Training | Sleep disorders | Insomnia | Psychopharmacology | Documents | Clinical medicine | Circulation
Journal Article
Genes & Development, ISSN 0890-9369, 02/1997, Volume 11, Issue 4, pp. 476 - 491
The Pax5 gene coding for the transcription factor BSAP has an essential role in B lymphopoiesis and midbrain development. Here we present a detailed analysis... 
Journal Article
Schizophrenia Bulletin, ISSN 0586-7614, 11/2013, Volume 39, Issue 6, pp. 1343 - 1351
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 7/2012, Volume 26, Issue 7, pp. 899 - 952
Journal Article